Dear Neuroendocrine Cancer Community, Dr. Richard R.P. Warner For six decades years, the Carcinoid Cancer Foundation (CCF) has been a pillar of education, advocacy, and support for the neuroendocrine tumor (NET) community. Founded by the late Dr. Richard R.P. Warner , CCF helped shape the modern landscape of NET patient education and touched countless lives. The Neuroendocrine Cancer Foundation (NCF) now enters a new chapter as we carry forward this legacy. We have been entrusted with...

2025 was a year of meaningful progress in neuroendocrine cancer. New treatments, new clinical trial data, and expanded research efforts continue to improve care for people living with diverse neuroendocrine cancers including neuroendocrine tumor (NET), neuroendocrine carcinoma (NEC), and pheochromocytoma and paraganglioma (PPGL). Below is an overview of some of the most important developments of the year. Year-in-Review: NET and NEC Updates Download the transcript of this video >>> Dr. Udhay...

Every year on November 10th , people around the world unite to raise awareness, advance scientific progress, and amplify the voices of those affected by neuroendocrine cancer. This year, approximately 75 neuroendocrine cancer patients, loved ones, clinicians, and industry partners  gathered in Miami, Florida  for the Neuroendocrine Cancer Foundation World NET Cancer Day Symposium  on November 9th . Together, we shared information, connection, and hope—reminding one another that we are not...